About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Stanford University
›
Department of Radiation Oncology
›
Most Cited Articles
Department of Radiation Oncology (most cited articles)
Stanford University
6.3K
Articles
319.7K
Citations
4
avg. Impact Factor
230
h-index
Most Cited Articles of Department of Radiation Oncology
Title
Journal
Year
Citations
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Proceedings of the National Academy of Sciences of the United States of America
2001
8.3K
Repeated observation of breast tumor subtypes in independent gene expression data sets
Proceedings of the National Academy of Sciences of the United States of America
2003
4.3K
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Blood
2016
4.1K
Robust enumeration of cell subsets from tissue expression profiles
Nature Methods
2015
3.9K
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy
2016
3.8K
National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project
Cancer
1982
3.4K
Oncology meets immunology: the cancer-immunity cycle
Immunity
2013
3.1K
Next-generation DNA sequencing
Nature Biotechnology
2008
3K
Matrix crosslinking forces tumor progression by enhancing integrin signaling
Cell
2009
2.7K
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
New England Journal of Medicine
2016
2.6K
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Lancet, The
2016
2.3K
Purification and characterization of mouse hematopoietic stem cells
Science
1988
2.2K
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Nature
1996
2K
Exploiting tumour hypoxia in cancer treatment
Nature Reviews Cancer
2004
2K
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Nature
2009
1.9K
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
Current Biology
2000
1.7K
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Cell Metabolism
2006
1.6K
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
Nature Medicine
1996
1.6K
Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types
PLoS ONE
2012
1.5K
IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
Blood
1997
1.4K
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Nature Medicine
2014
1.4K
A cell-surface molecule involved in organ-specific homing of lymphocytes
Nature
1983
1.3K
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
New England Journal of Medicine
2018
1.3K
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nature Reviews Cancer
2008
1.2K
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Lancet, The
2017
1.2K
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.